Semaglutide sodium is a long‑acting analog of human glucagon‑like peptide‑1 (GLP‑1) and an agonist of the human GLP‑1 receptor. Semaglutide has potential for research in type 2 diabetes mellitus.
This product is a long‑acting GLP‑1 receptor agonist analog produced by recombinant DNA technology and chemical modification. Compared with human GLP‑1, it contains two amino acid substitutions: Ala8 replaced with Aib8 (2‑aminoisobutyric acid) and Lys34 replaced with Arg34. Acetylation with a fatty diacid occurs at Lys26 to form semaglutide. The product is recombinantly expressed in Escherichia coli.
规格
产品名称
司美格鲁肽钠盐
别名
索马鲁肽 | 索马鲁肽对照品 | 索马鲁泰 | 司美鲁
规格或纯度
无动物源, 无载体, ≥99%(HPLC)
表达系统
E. coli
无载体
Yes
无动物源
Yes
来源
重组表达
预测分子量
4113.58 (free base)
CAS编号和信息
910463-68-2(free base)
分子类型
蛋白质
产品线
生物产品
储存与运输
物理形态
冻干(Lyophilized)
储存缓冲液
Lyophilized from ddH₂O with mannitol as a protective agent.
复溶
Reconstitute in sterile water or physiological saline.